Division of Cardiology, Department of Medicine, University of Hong Kong Queen Mary Hospital, Hong Kong, China.
Division of Cardiology, Department of Medicine, University of Hong Kong Shenzhen Hospital, Hong Kong, China.
J Am Heart Assoc. 2018 Jul 13;7(14):e009020. doi: 10.1161/JAHA.118.009020.
The Model for End-stage Liver Disease excluding international normalized ratio (MELD-XI) score and the modified MELD score with albumin replacing international normalized ratio (MELD-Albumin) score, which reflect both liver and renal function, have been reported as predictors of adverse events in liver and heart disease. Nonetheless, their prognostic value in patients undergoing tricuspid annuloplasty has not been addressed.
A total of 394 patients who underwent tricuspid annuloplasty were evaluated. Baseline clinical, laboratory, and echocardiographic parameters were recorded. Adverse outcome was defined as the occurrence of heart failure requiring admission or all-cause mortality. Patients who underwent tricuspid annuloplasty had a high prevalence of preoperative hepatorenal dysfunction that was more common in patients with severe tricuspid regurgitation than those with mild to moderate tricuspid regurgitation. The MELD-XI and MELD-Albumin scores were excellent predictors of 1-year adverse outcome (area under the curve: 0.69 and 0.75, respectively). Kaplan-Meier survival curve demonstrated that a high score on MELD-XI (≥12.0) and MELD-Albumin (≥10.7) was associated with an increased risk of adverse events. During a median follow-up of 40 months, both MELD-XI and MELD-Albumin scores were significantly associated with adverse outcome, even after adjusting for potential confounding factors. Significant improvement of hepatorenal function at 1 year postoperation was noted only in patients who had no adverse events, not in those who experienced an adverse outcome.
Both MELD-XI score and MELD-Albumin score can provide useful information to predict adverse outcome in patients undergoing tricuspid annuloplasty. The present study supports monitoring of modified MELD score to improve preoperative risk stratification of these patients.
模型终末期肝病评分排除国际标准化比值(MELD-XI)和改良 MELD 评分白蛋白替代国际标准化比值(MELD-Albumin),反映了肝脏和肾功能,已被报道为肝脏和心脏疾病不良事件的预测因子。然而,它们在接受三尖瓣环成形术的患者中的预后价值尚未得到解决。
共评估了 394 例行三尖瓣环成形术的患者。记录了基线临床、实验室和超声心动图参数。不良结局定义为心力衰竭需要入院或全因死亡率。接受三尖瓣环成形术的患者术前肝肾功能障碍发生率较高,且在重度三尖瓣反流患者中比轻度至中度三尖瓣反流患者更常见。MELD-XI 和 MELD-Albumin 评分是 1 年不良结局的优秀预测因子(曲线下面积:分别为 0.69 和 0.75)。Kaplan-Meier 生存曲线表明,MELD-XI(≥12.0)和 MELD-Albumin(≥10.7)评分较高与不良事件风险增加相关。在中位数为 40 个月的随访期间,即使在调整了潜在混杂因素后,MELD-XI 和 MELD-Albumin 评分仍与不良结局显著相关。仅在无不良事件的患者中观察到术后 1 年肝肾功能显著改善,而在发生不良结局的患者中则没有。
MELD-XI 评分和 MELD-Albumin 评分均可提供有用信息,以预测接受三尖瓣环成形术的患者的不良结局。本研究支持监测改良 MELD 评分,以改善这些患者的术前风险分层。